SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HTDS - Hard To Treat Diseases
HTDS 0.000001000-95.0%May 28 12:33 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: donpat who wrote (133)7/6/2005 4:11:17 AM
From: rrm_bcnu  Read Replies (1) of 271
 
Incorrect donpat. If you read the PR's and the Finding's Of Fact at the PACER site you will see that HTDS will maximize shareholder value through manufacturing and distribution partnerships with major pharma companies. There are four waiting to bid on Tubrcin. A bidding war is in the offing, and the winner will be HTDS shareholders.

cheers

rrm
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext